Metraipolis › archive › dc_bd401cfce087

State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41864828
DOI
10.1016/j.zemedi.2026.03.011
License (as archived)
solo-consultazione
Archived
2026-11-04T03:36:02.181Z
SHA-256 of the archived text
d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6
Stable URL of this page
https://metraipolis.com/documento/dc_bd401cfce087

How to cite

State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828 — Europe PMC (en), https://europepmc.org/article/MED/41864828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd401cfce087 (Metraipolis archive dc_bd401cfce087, sha256 d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6)
BibTeX
@misc{dcbd401cfce087,
  title = {State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41864828},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd401cfce087; sha256 d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41864828. Agents can read the archived copy with the MCP tool read_document.